Diligence memo · auto-generated · as of July 2, 2026
Dragonfly Endoscopy Inc.
Dragonfly Endoscopy Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Dragonfly Endoscopy Inc. operates in Other Health Care, based in ENGLEWOOD,.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Dragonfly Endoscopy Inc. has raised $13M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $13M on 2022-02-22.
Most recent recorded round closed around 2022-02-22.
Valuation (modeled)modeled
Provath models Dragonfly Endoscopy Inc. at approximately $142M (range $16M–$528M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 3.87× the median modeled value of Series A Other Health Care companies in 2022–2024 (196 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 4.4 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 79% of Other Health Care peers (5377 compared).
Modeled value ranks above 84% of those peers.
Closest niche peers: CareHarmony, Inc., NuvoAir Holdings, Inc., Post Acute Recovery, Inc., Micro Interventional Devices, Inc., Etiometry Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.